on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group's Stake Disclosure in Mural Oncology plc
The Vanguard Group, Inc. has submitted Form 8.3 under the Irish Takeover Panel rules, revealing its position in Mural Oncology plc's securities. As of 10 June 2025, Vanguard holds 773,059 of Mural Oncology's $0.01 ordinary shares, representing a 4.48% shareholding in the company.
This disclosure is made under Rule 8.3 of the Irish Takeover Panel Act, 1997. The Vanguard Group did not report any connections with other offerors or offerees, and no additional disclosures were made regarding other parties' securities.
Recent transactions included the purchase of 176 and sale of 32 Mural Oncology shares at $2.55 per unit. No cash-settled or stock-settled derivatives transactions were disclosed. There are no indemnity agreements or arrangements related to Mural Oncology's securities.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news